Related Experiment Videos
Azithromycin: an interim analysis
1Infectious Diseases Unit, Cameron Hospital, Windygates, UK.
The Journal of International Medical Research
|November 1, 1991
Summary
Azithromycin, a new azalide antibiotic, shows effectiveness against Gram-positive and some Gram-negative bacteria like Haemophilus influenzae. Clinical trials confirm its efficacy and tolerability for various infections with short-course, once-daily dosing.
Area of Science:
- Pharmacology
- Microbiology
- Clinical Medicine
Background:
- Azithromycin is a novel azalide antibiotic related to erythromycin.
- In vitro studies indicate broad-spectrum activity against Gram-positive and certain Gram-negative pathogens.
Purpose of the Study:
- To review clinical trials evaluating azithromycin's efficacy and tolerability.
- To assess the suitability of short-course, once-daily azithromycin regimens for common bacterial infections.
Main Methods:
- Review of clinical trial data for azithromycin treatment regimens.
- Evaluation of in vitro antimicrobial activity and pharmacokinetic properties.
Main Results:
- Azithromycin demonstrates comparable activity to erythromycin against Gram-positive bacteria.
- Enhanced activity against specific Gram-negative bacteria, including Haemophilus influenzae.
- Excellent tissue penetration and prolonged elimination half-life support short-course therapy.
Conclusions:
- Azithromycin is clinically and bacteriologically effective for respiratory tract, skin, and soft tissue infections.
- Short-course, once-daily azithromycin regimens are well-tolerated compared to standard antibiotic treatments.